CClinicalTrials.gg
CompletedNCT06906666Updated Feb 10, 2026

Analysis of Injury Risk Factors in Elite Athletes

An observational study in Athletic Injuries, sponsored by University of Oviedo. Completed at 1 site in Spain. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-10.

Sponsored by University of Oviedo · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
81
Ages
18 Years to 35 Years
Sex
All
01

Study summary

Background information. The different disciplines of athletics place high physical demands on athletes. These different categories of running vary in terms of physical effort and duration, generating different levels of risk of injury. The description of the main injuries that affect elite athletes in the different athletics disciplines, as well as the identification of the specific risk factors of each discipline, will allow the identification of preventive measures to be implemented.

Objective. To identify the risk factors for tendon injury in professional long- and middle-distance athletes, according to the type of event, and to identify the best predictive model for tendon injuries based on anthropometric and athletic variables.

Method. Ambispective cohort study. 81 elite athletes will be recruited. The primary variable will be the number of tendon injuries in the last three seasons. The secondary and modifying variables will be: age (in completed years), weekly training load (in minutes), type of footwear (sneakers without carbon plate, sneakers with carbon plate, spiked sneakers without carbon plate and spiked sneakers with carbon plate), diet (balanced, high in carbohydrates, high-protein, controlled hypocaloric and adapted to the training cycle) and the regular practice of another physical activity. The possible confounding variables will be the body mass index, the date of tendon injuries in that period and the time spent as a federated athlete (in completed months). The analysis will calculate the risk of injury in these athletes and assess the influence of confounding factors and trend analysis on the primary variable, stratified by possible confounding factors.

Expected results. To calculate the risk of injury in elite athletes based on anthropometric and sociodemographic variables. To identify the predictive model of tendon injuries in elite athletes

02

Conditions studied

  • Athletic Injuries

Browse trials for

Keywords

  • Muscle Injury
  • Athletics
  • Risk
  • Secondary Prevention
  • Physiotherapy
03

In context

Athletic Injuries

270 studies on the registry are indexed under Athletic Injuries; 42 are open to participants now.

This study's enrollment of 81 is below the median of 100 across 100 observational studies indexed under Athletic Injuries.

Browse Athletic Injuries studies →

Lead sponsor

University of Oviedo is the lead sponsor of 47 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Elite athletes

Inclusion criteria

  • Elite federated athletes
  • Who have not undergone previous musculoskeletal surgery in the seasons under study
  • Who were federated at least one year before the study period
  • Sign the informed consent document.

Exclusion criteria

Exclusion Criteria:

  • Athletes who have not participated in competition, during the study seasons, for a period of more than 6 months due to a musculoskeletal injury
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
81 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Observacional group

    Other: Athletes sample

Interventions

  • OtherAthletes sample

    Elite athletes in whom the risk of injury will be calculated and the influence of confounding factors will be assessed through a personal interview.

    Also known as: Elite athletes group

06

What researchers measure

Primary outcomes

  1. Measurement of number of lower limb tendon injuries

    The primary variable will be the number of lower limb tendon injuries in the last three seasons

    Time frame: Screening visit

Secondary outcomes

  1. Measurement of age

    The measurement of age (measured in completed years) will be a secondary variable.

    Time frame: Screening visit

  2. Measurement of the weekly training load

    The measurement of the weekly training load (measured in minutes) will be a secondary variable.

    Time frame: Screening visit

  3. Measurement of the type of footwear

    The evaluation of the type of footwear (with the response options: shoe without carbon plate, shoe with carbon plate, spike shoe without carbon plate and spike shoe with carbon plate) will be a secondary variable.

    Time frame: Screening visit

  4. Measurement of the type of diet

    The evaluation of the type of diet (with the response options: balanced, rich in carbohydrates, rich in proteins and adapted to the training cycle) will be a secondary variable.

    Time frame: Screening visit

  5. Measurement of the practice of another physical activity

    The evaluation of the practice of another physical activity on a regular basis will be a secondary variable.

    Time frame: Screening visit

Other outcomes

  1. Measurement of the body mass index

    The measurement of the body mass index (measured in kg/m2) will be a possible confounding variable.

    Time frame: Screening visit

  2. Measurement of the date of tendon injuries

    The date of tendon injuries in that period will be a possible confounding variable.

    Time frame: Screening visit

  3. Measurement of federated time

    The evaluation of federated time (measured in completed months) will be a possible confounding variable.

    Time frame: Screening visit

07

Study locations

1 site
  • University of Oviedo
    Oviedo, Principality of Asturias 33006, Spain
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06906666
Lead sponsor
University of Oviedo
Responsible party
Ruben Cuesta Barriuso (Principal Investigator, University of Oviedo) — Principal investigator
First posted
Apr 2, 2025
Start date
Mar 31, 2025
Primary completion
Apr 28, 2025
Completion
May 15, 2025
Last update
Feb 10, 2026

Study contacts

Rubén Cuesta-Barriuso
study director · Universidad de Oviedo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion